Results 51 to 60 of about 1,217,759 (290)
Vaccines, 2023 Background: The recommended booster third dose of vaccination against COVID-19 in cancer patients seems reasonable to protect them against a severe disease course.
Urska Janzic +8 more
doaj +1 more source
Solid Pseudopapillary Neoplasm of the Pancreas in Children and Adolescents: Expert Recommendations
Pediatric Blood &Cancer, EarlyView.ABSTRACT Solid pseudopapillary neoplasm of the pancreas (SPN) is a rare low‐grade malignant exocrine pancreatic tumor, mostly discovered during the second decade of life in females, with a very good prognosis, provided microscopically complete surgical excision is achieved.
Sabine Irtan +18 more
wiley +1 more source
Optimal Social Limitation Reduction under Vaccination and Booster Doses
Proceedings of the 19th International Conference on Informatics in Control, Automation and Robotics, 2022 In the paper an optimal control solution is provided for the containment of the number of infected individuals in COVID-19 pandemic under vaccination campaign. The possibility to dynamically change the cost of the controls according to the ongoing evolution within the design procedure allows to get great efforts in presence of very serious disease ...
Di Giamberardino, Paolo +1 more
openaire +3 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider +15 more
wiley +1 more source
Vaccines, 2023 Little is known about the long-term durability of the induced immune response in subjects with obesity, particularly in those with an abdominal distribution of adipose tissue.
Alexis Elias Malavazos +19 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Children with sickle cell anemia (SCA) in low‐income settings are at risk of severe malnutrition, but optimal nutritional management has not been established. We evaluated an intensified ready‐to‐use therapeutic food (RUTF) regimen in children with persistent severe malnutrition after initial treatment and assessed whether early ...
Safiya Gambo +9 more
wiley +1 more source
Flow of UB-612 Phase-2 primary 2-dose series with extension booster.
, 2023 The study design of the Phase-2 primary 2-dose series (100 μg dose; 28 days apart) of UB-612; and the extension study of booster vaccination [NCT04773067] conducted between Oct. 16, 2021 and Apr. 16, 2022.
Chang Yi Wang (9711378) +8 more
core +1 more source
Human Vaccines & Immunotherapeutics, 2022 Japanese encephalitis is the main cause of viral encephalitis in Asia. In a previous single-arm vaccine trial, an inactivated chromatographically purified Japanese encephalitis Vero cell vaccine (CVI-JE; JEVACTM) was safe and immunogenic in 152 Thai ...
Weerawan Hattasingh +10 more
doaj +1 more source
Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine +17 more
wiley +1 more source
Human Vaccines & Immunotherapeutics, 2022 This study aimed to explore the relationship between post-vaccination adverse reactions, decision regret, and willingness to pay (WTP) for the booster dose. An online survey was conducted in Taizhou, China.
Chengwen Luo +3 more
doaj +1 more source